// App-Quantinova.ai

P5-19-22 : A phase I clinical trial of entinostat and lapatinib in patients with trastuzumab refractory HER2-positive metastatic breast cancer

Researchers

Presenter

  • Ueno NT

Principal Investigators

  • Jackson SA

  • Booser DJ

  • Giordano SH

  • Gonzalez-Angulo AM

  • Murray JL

  • Valero V

  • Lee J

  • Faruqi FA

  • Willey J

  • Alvarez RH

Medical Centers

  • UT M.D. Anderson, Houston, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Breast cancer

  • Neutropenia

  • Dyspnea

  • Solid malignancies

  • Anemia

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab

  • Entinostat

  • Lapatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved